Filing Details
- Accession Number:
- 0001140361-21-004535
- Form Type:
- 13G Filing
- Publication Date:
- 2021-02-12 11:21:09
- Filed By:
- Schroder Investment Management North America Inc/ De
- Company:
- Evofem Biosciences Inc. (NASDAQ:EVFM)
- Filing Date:
- 2021-02-12
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Schroder Investment Management Ltd | 0 | 0 | 0 | 0 | 0 | 0% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)
EVOFEM BIOSCIENCES INC
(Name of Issuer)
COM
(Title of Class of Securities)
30048L104
(CUSIP Number)
12/31/2020
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☑ | Rule 13d-1(b) |
☐ | Rule 13d-1(c) |
☐ | Rule 13d-1(d) |
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures
provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 30048L104 |
1 | NAMES OF REPORTING PERSONS | | | ||
Schroder Investment Management Ltd. | | | |||
| | ||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | ||||
(a)☐ | |||||
(b)☐ | | | |||
3 | SEC USE ONLY | | | ||
| | | |||
| | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | ||
United Kingdom | | | |||
| | ||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER | | | |
0 | | | |||
| | ||||
6 | SHARED VOTING POWER | | | ||
0 | | | |||
| | ||||
7 | SOLE DISPOSITIVE POWER | | | ||
0 | | | |||
| | ||||
8 | SHARED DISPOSITIVE POWER | | | ||
0 | | | |||
| | ||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | ||
0 | | | |||
| | ||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | | | ||
☐ | | | |||
| | ||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | ||
0% of outstanding shares | | | |||
| | ||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | | | ||
FI | | | |||
| |
Item 1.
(a) | Name of Issuer EVOFEM BIOSCIENCES INC |
(b) | Address of Issuer’s Principal Executive Offices 12400 High Bluff Drive, Suite 600 San Diego, CA 92130 |
Item 2.
(a) | Name of Person Filing Schroder Investment Management North America Inc |
(b) | Address of Principal Business Office or, if none, Residence 7 Bryant Park, 19th Floor New York, NY 10018 |
(c) | Citizenship USA |
(d) | Title of Class of Securities COM |
(e) | CUSIP Number 30048L104 |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
(a) | ☐ | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
(b) | ☐ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
(c) | ☐ | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
(d) | ☐ | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). |
(e) | ☒ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
(f) | ☐ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
(g) | ☐ | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); |
(h) | ☐ | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
(i) | ☐ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
(j) | ☐ | Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
Item 4. | Ownership |
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) | Amount beneficially owned: 0 | |
(b) | Percent of class: 0% of outstanding shares | |
(c) | Number of shares as to which the person has: | |
(i) | Sole power to vote or to direct the vote 0 | |
(ii) | Shared power to vote or to direct the vote 0 | |
(iii) | Sole power to dispose or to direct the disposition of 0 | |
(iv) | Shared power to dispose or to direct the disposition of 0 |
Item 5. | Ownership of Five Percent or Less of a Class |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.
Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Not applicable.
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company |
Not applicable.
Item 8. | Identification and Classification of Members of the Group |
Schroder Investment Management Ltd., is a registered investment adviser with their respective home country regulator and under common control with the adviser. Schroder Investment Management Ltd is located in the United Kingdom at 1 London Wall
Place, London EC2Y 5AU. Schroder Investment Management North America Inc. disclaims the existence of a group.
Item 9. | Notice of Dissolution of Group |
Not applicable.
Item 10. | Certification |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
February 11, 2021 | |||
By: | /s/ Marc Brookman |
Name: | Marc Brookman** | |
Title: | Chief Executive Officer | |
Schroder Investment Management North America Inc | ||
**Authorized by Power of Attorney to sign on behalf of the following Advisor: | ||
Schroder Investment Management Ltd. |
5